Share-based Payment Arrangement, Expense in USD of AGILE THERAPEUTICS INC from 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Agile Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2012 to Q2 2024.
  • Agile Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $284K, a 41.1% decline year-over-year.
  • Agile Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2014 was $1.38M, a 3.2% increase from 2013.
  • Agile Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2013 was $1.34M, a 101% increase from 2012.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $284K -$198K -41.1% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $333K -$165K -33.1% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024
Q2 2023 $482K -$187K -28% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 $498K -$266K -34.8% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q3 2022 $536K -$351K -39.6% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $669K -$174K -20.6% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $764K +$22K +2.97% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q3 2021 $887K +$240K +37.1% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $843K +$4K +0.48% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $742K +$121K +19.5% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 $647K +$269K +71.2% 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021
Q2 2020 $839K +$360K +75.2% 01 Apr 2020 30 Jun 2020 10-Q 26 Jul 2021
Q1 2020 $621K +$131K +26.7% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021
Q3 2019 $378K -$343K -47.6% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $479K -$508K -51.5% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 $490K -$629K -56.2% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q3 2018 $721K -$246K -25.4% 01 Jul 2018 30 Sep 2018 10-Q 28 Oct 2019
Q2 2018 $987K +$62K +6.7% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 $1.12M +$284K +34% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019
Q3 2017 $967K +$27K +2.87% 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018
Q2 2017 $925K -$30K -3.14% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018
Q1 2017 $835K +$124K +17.4% 01 Jan 2017 31 Mar 2017 10-Q 07 May 2018
Q3 2016 $940K +$194K +26% 01 Jul 2016 30 Sep 2016 10-Q 06 Nov 2017
Q2 2016 $955K +$217K +29.4% 01 Apr 2016 30 Jun 2016 10-Q 28 Jul 2017
Q1 2016 $711K 01 Jan 2016 31 Mar 2016 10-Q 08 May 2017
Q3 2015 $746K 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 $738K 01 Apr 2015 30 Jun 2015 10-Q 08 Aug 2016

AGILE THERAPEUTICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2014 $1.38M +$42.9K +3.2% 01 Jan 2014 31 Dec 2014 10-K 26 Mar 2015
2013 $1.34M +$672K +101% 01 Jan 2013 31 Dec 2013 10-K 26 Mar 2015
2012 $665K 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.